Arkolith/Funds/TRV GP VI, LLC

TRV GP VI, LLC

CIK 1990716
Holdings as of Jun 30, 2026·disclosed Aug 10, 2026·~41-day 13F lag·13F-HR
Active Filer

TRV GP VI, LLC holds a concentrated book of 4 stocks worth $232.3M as of Q2 2026 (disclosed Aug 10, 2026, a ~41-day 13F lag). This quarter they opened Seaport Thereapeutics, Inc.. Their largest long position is Septerna Inc at 61% of the equity book.

Opened
2
bought for the first time
Added to
0
already held, bought more
no adds
Trimmed
0
sold some, still holds it
no trims
Sold out
0
exited the position entirely
nothing exited

Concentration

Top-heavy: concentrated book

Top 5 holdings
100%
Top 10 holdings
100%
Top 20 holdings
100%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Direct sector allocation

81% mapped to company sectors

Health Care
81%
ETF / fund or unclassified
19%

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices, no cost basis

Bought
  • SEAPORT THEREAPEUTICS, INC.
    New$44.8M
Trimmed / exited

No trims or exits this quarter.

Funds with the most overlap

Other tracked managers holding the same core names as TRV GP VI, LLC

Manager / fundShared namesTheir $ in those
Siren, L.L.C.4 / 4$307.3M
GEODE CAPITAL MANAGEMENT, LLC4 / 4$176.7M
Integrated Wealth Concepts LLC4 / 4$29K
FMR LLC3 / 4$432.1M
BlackRock, Inc.3 / 4$305.2M
ADAGE CAPITAL PARTNERS GP, L.L.C.3 / 4$273.2M
GOLDMAN SACHS GROUP INC3 / 4$268.1M
STATE STREET CORP3 / 4$242.9M

Ranked by the share of each fund's own book sitting in the names it shares with TRV GP VI, LLC: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

4 positions
#SecurityValueShares% PortLast moveHistory
1Septerna, Inc.
COM
$141.0M4.21M
60.7%
Held
2Seaport Thereapeutics, Inc.
COM
$44.8M2.06M
19.3%
New
New position
3Rapport Therapeutics, Inc.
COM
$40.4M969.2K
17.4%
Held
4Tango Therapeutics, Inc.
COM
$6.1M194.2K
2.6%
Held
Showing all 4 positions
Build

Build on this 13F portfolio

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Build

Ask your agent what TRV GP VI, LLC owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/1990716/holdings"
Ask your agent
Use Arkolith to show TRV GP VI, LLC's latest
holdings, largest changes, and filing provenance.

Filing history

As-of date vs the date the SEC received each filing

QuarterAs ofFiledPositionsValueForm
Q2 2026Jun 30, 2026Aug 10, 20264$232.3M13F-HR
Q1 2026Mar 31, 2026May 7, 20263$135.6M13F-HR
Q4 2025Dec 31, 2025Feb 13, 20263$148.5M13F-HR
Q3 2025Sep 30, 2025Nov 13, 20253$109.6M13F-HR
Q2 2025Jun 30, 2025Aug 8, 20254$64.2M13F-HR
Q1 2025Mar 31, 2025May 9, 20254$42.0M13F-HR
Q4 2024Dec 31, 2024Feb 13, 20254$116.9M13F-HR

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.